The management at Granlen has a long history of implementing, integrating, and managing chemical automation in the drug discovery process. Our team has helped to integrate combinatorial chemistry techniques into the discovery programs at several companies and offer consultation services for companies interested in integrating automation into their program. We have a long history of method development and have:
• Provided solution- and solid-phase parallel syntheses
• Provided solution-phase indexed libraries
• Generated the largest novel nucleoside library